Prospective Evaluation of Quantitative F-18-FDG-PET/CT for Pre-Operative Thoracic Lymph Node Staging in Patients with Lung Cancer as a Target for Computer-Aided Diagnosis.
PET/CT
computer aided diagnosis
lung cancer
lymph node metastases
quantification
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
27 Mar 2023
27 Mar 2023
Historique:
received:
28
02
2023
revised:
22
03
2023
accepted:
24
03
2023
medline:
14
4
2023
entrez:
13
4
2023
pubmed:
14
4
2023
Statut:
epublish
Résumé
Pre-operative assessment of thoracic lymphonodal (LN) involvement in patients with lung cancer (LC) is crucial when choosing the treatment modality. Visual assessment of F-18-FDG-PET/CT (PET/CT) is well established, however, there is still a need for prospective quantitative data to differentiate benign from malignant lesions which would simplify staging and guide the further implementation of computer-aided diagnosis (CAD). In this prospective study, 37 patients with confirmed lung cancer (m/f = 24/13; age: 70 [52-83] years) were analyzed. All patients underwent PET/CT and quantitative data (standardized uptake values) were obtained. Histological results were available for 101 thoracic lymph nodes. Quantitative data were matched to determine cut-off values for delineation between benign vs. malignant lymph nodes. Furthermore, a scoring system derived from these cut-off values was established. Statistical analyses were performed through ROC analysis. Quantitative analysis revealed the optimal cut-off values ( Quantitative analysis of F-18-FDG-PET/CT data provides reliable results for delineation between benign and malignant thoracic lymph nodes. Thus, quantitative parameters can improve diagnostic accuracy and reliability and can also facilitate the handling of the steadily increasing number of clinical examinations.
Identifiants
pubmed: 37046481
pii: diagnostics13071263
doi: 10.3390/diagnostics13071263
pmc: PMC10093566
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Clin Nucl Med. 2008 Oct;33(10):681-7
pubmed: 18806567
Eur Radiol. 2016 Aug;26(8):2808-18
pubmed: 26560731
Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):224-237
pubmed: 30350009
PLoS One. 2018 Nov 9;13(11):e0207192
pubmed: 30412613
Eur J Cardiothorac Surg. 2007 Jul;32(1):1-8
pubmed: 17448671
J Thorac Oncol. 2008 Sep;3(9):971-8
pubmed: 18758298
Acta Oncol. 2017 May;56(5):706-712
pubmed: 28094665
Ann Thorac Surg. 2000 Nov;70(5):1620-3
pubmed: 11093497
J Nucl Med. 2007 Nov;48(11):1761-6
pubmed: 17942814
Ann Thorac Surg. 2000 Nov;70(5):1641-3
pubmed: 11093501
Nucl Med Biol. 2011 Apr;38(3):347-51
pubmed: 21492783
Clin Lung Cancer. 2015 Nov;16(6):e253-8
pubmed: 26163919
Eur Respir J. 2003 Apr;21(4):567-73
pubmed: 12762337
Eur J Cardiothorac Surg. 2009 Oct;36(4):731-6
pubmed: 19632852
EJNMMI Res. 2011 Jul 6;1:8
pubmed: 21841971
Biomed Pharmacother. 2017 Apr;88:1038-1045
pubmed: 28192877
Respirology. 2015 Jan;20(1):129-37
pubmed: 25263085
Ann Thorac Surg. 2005 Jan;79(1):375-82
pubmed: 15620991
Lancet Oncol. 2020 Apr;21(4):581-592
pubmed: 32171429
Chest. 1997 Jun;111(6):1718-23
pubmed: 9187199
Thorax. 2007 Aug;62(8):696-701
pubmed: 17687098
J Neurointerv Surg. 2019 May;11(5):497-502
pubmed: 30415227
Cochrane Database Syst Rev. 2014 Nov 13;(11):CD009519
pubmed: 25393718
Eur J Cardiothorac Surg. 2014 May;45(5):787-98
pubmed: 24578407
J Clin Med. 2018 Nov 08;7(11):
pubmed: 30413107
Am J Nucl Med Mol Imaging. 2018 Apr 25;8(2):100-109
pubmed: 29755843
Oncology. 2020;98(6):344-362
pubmed: 30472716
J Clin Oncol. 2007 Feb 10;25(5):571-8
pubmed: 17242397
J Am Coll Radiol. 2017 May;14(5):587-595
pubmed: 28372962
Nucl Med Mol Imaging. 2017 Jun;51(2):140-146
pubmed: 28559938
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):328-54
pubmed: 25452219
Eur J Radiol. 2016 Aug;85(8):1345-50
pubmed: 27423672